Scope and Applications of Nanomedicines for the Management of Neuropathic Pain.

Molecular Pharmaceutics
Yaswanth KuthatiChih Shung Wong

Abstract

Neuropathic pain, resulting from the dysfunction of the peripheral and central nervous system, occurs in a variety of pathological conditions including trauma, diabetes, cancer, HIV, surgery, multiple sclerosis, ischemic attack, alcoholism, spinal cord damage, and many others. Despite the availability of various treatment strategies, the percentage of patients achieving adequate pain relief remains low. The clinical failure of most effective drugs is often not due to a lack of drug efficacy but due to the dose-limiting central nervous system (CNS) toxicity of the drugs that preclude dose escalation. There is a need for cross-disciplinary collaborations to meet these challenges. In this regard, the integration of nanotechnology with neuroscience is one of the most important fields. In recent years, promising preclinical research has been reported in this field. This review highlights the current challenges associated with conventional neuropathic pain treatments, the scope for nanomaterials in delivering drugs across the blood-brain barrier, and the state and prospects of nanomaterials for the management of neuropathic pain.

References

Jul 1, 1981·Archives of General Psychiatry·A H Glassman, J T Bigger
Jun 1, 1996·Neurobiology of Disease·M C RowbothamH L Fields
Dec 16, 1998·Neurobiology of Disease·H L FieldsR Baron
Oct 2, 2004·Protein Science : a Publication of the Protein Society·Peter B StathopulosElizabeth M Meiering
Nov 19, 2004·The Journal of Neuroscience : the Official Journal of the Society for Neuroscience·A Vania ApkarianDarren R Gitelman
Jul 24, 2007·Progress in Neurobiology·X NavarroAntoni Valero-Cabré
Dec 18, 2007·Proceedings of the National Academy of Sciences of the United States of America·Fletcher A WhiteRichard J Miller
Jun 28, 2008·Pain·John D Loeser, Rolf-Detlef Treede
Oct 23, 2008·Molecular Therapy : the Journal of the American Society of Gene Therapy·Toyokazu TsuchiharaHiroshi Arino
Apr 15, 2011·Journal of Drug Delivery·Daniel A Balazs, Wt Godbey
Jul 29, 2011·The Journal of Neuroscience : the Official Journal of the Society for Neuroscience·Stefania EcheverryJi Zhang
Oct 22, 2011·Cellular and Molecular Life Sciences : CMLS·Paul GalvinRonan MacLoughlin
Dec 24, 2011·Journal of the American Chemical Society·Carl D WalkeyWarren C W Chan
May 15, 2012·Advanced Drug Delivery Reviews·P Couvreur
Jul 19, 2012·Muscle & Nerve·Simon R LevinsonMichael A Henry
Jul 24, 2012·Science·Jeffrey A Hubbell, Ashutosh Chilkoti
Sep 13, 2012·Pain Research and Treatment·Shaheen E Lakhan, Mihaela Avramut
Oct 10, 2012·Proceedings of the National Academy of Sciences of the United States of America·Sahadev A ShankarappaDaniel S Kohane
Jan 19, 2013·Molecular Pharmaceutics·Michele CaragliaSabatino Maione
Mar 23, 2013·Journal of Controlled Release : Official Journal of the Controlled Release Society·Ellen C DenglerErin D Milligan
Jun 15, 2013·Journal of Nanoscience and Nanotechnology·Yaswanth KuthatiChia-Hung Lee
Jun 25, 2013·Pain·Ru-Rong JiMaiken Nedergaard
Sep 13, 2013·BioMed Research International·Amruta MankeYon Rojanasakul
Nov 30, 2013·International Journal of Pharmaceutics·D IbraheemH Fessi
May 3, 2014·OncoTargets and Therapy·Ece Esin, Suayib Yalcin
Oct 31, 2014·AAPS PharmSciTech·Jigar LalaniAmbikanandan Misra
Dec 5, 2014·PharmacoEconomics·Adela Hruby, Frank B Hu
Dec 6, 2014·Pain Research & Management : the Journal of the Canadian Pain Society = Journal De La Société Canadienne Pour Le Traitement De La Douleur·Dwight MoulinUNKNOWN Canadian Pain Society
Dec 30, 2014·Journal of Drug Targeting·Oliver LinsellJohn C Ashton
Jan 28, 2015·Neoplasia : an International Journal for Oncology Research·Maxim A ShevtsovAlexander M Ischenko
Jul 15, 2015·International Journal of Nanomedicine·Xiaoli FengLimin Wei
Aug 19, 2015·Recent Patents on Drug Delivery & Formulation·Animikh RayAshim K Mitra
Oct 22, 2015·Advances in Experimental Medicine and Biology·Alison Burgess, Kullervo Hynynen
Nov 1, 2013·British Journal of Pain·Sabu James
Mar 19, 2016·The Journals of Gerontology. Series A, Biological Sciences and Medical Sciences·Zachary Zimmer, Sara Rubin
Jul 23, 2016·Scientific Reports·Vimala N BharadwajSarah E Stabenfeldt
Aug 2, 2016·Neuromodulation : Journal of the International Neuromodulation Society·Michael F SaulinoStanley P Fisher
Oct 5, 2016·Deutsches Ärzteblatt International·Andreas Binder, Ralf Baron
Jan 4, 2017·Anti-cancer Agents in Medicinal Chemistry·Nare SahakyanRobert Campbell
Feb 17, 2017·Nature Reviews. Disease Primers·Luana CollocaSrinivasa N Raja
Mar 28, 2017·Pharmaceutics·Upendra BulbakeWahid Khan

❮ Previous
Next ❯

Related Concepts

Related Feeds

HIV/AIDS-Related Malignancies

HIV/AIDS infection increases the risk of non-communicable diseases common in the aged including HIV/AIDS-related malignancies. Discover the latest research in HIV/AIDS-related malignancies.

Blood Brain Barrier Chips

The blood brain barrier (BBB) is comprised of endothelial cells that regulate the influx and outflux of plasma concentrations. Lab-on-a-chip devices allow scientists to model diseases and mechanisms such as the passage of therapeutic antibodies across the BBB. Discover the latest research on BBB chips here.

Blood Brain Barrier

The blood brain barrier is a border that separates blood from cerebrospinal fluid. Discover the latest search on this highly selective semipermeable membrane here.